Beneficial Electrophysiological Effects of Trimetazidine in Patients With Postischemic Chronic Heart Failure
- 25 January 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Cardiovascular Pharmacology and Therapeutics
- Vol. 15 (1), 24-30
- https://doi.org/10.1177/1074248409356431
Abstract
The aim of the study was to assess whether trimetazidine (TMZ) could affect dispersion of atrial depolarization and ventricular repolarization. Corrected QT interval (QTc), QTc dispersion (QTc-d), Tpeak—Tend, and Tpeak—Tend dispersion (Tpeak—Tend-d) were measured in 30 patients with chronic heart failure (CHF) before and 6 months after randomization to conventional therapy plus TMZ (17 patients) or conventional therapy alone (13 patients). After 6 months, QTc was significantly reduced in both groups, whereas QT-peak was increased only in control group. Tpeak—Tend-d decreased (from 63.53 ± 24.73 to 42.35 ± 21.07 milliseconds, P = .006) only in TMZ group. When subgrouped according to CHF etiology, only ischemic patients on TMZ showed Tpeak—Tend-d reduction (65.00 ± 27.14 vs 36.67 ± 11.55 milliseconds, P = .001 in ischemic patients; 60.00 ± 20.00 vs 56.00 ± 33.86 milliseconds, P = NS, in nonischemic). These electrophysiological properties indicate an undiscovered mechanism of action of TMZ, which could be useful in conditions at risk of major arrhythmias.Keywords
This publication has 30 references indexed in Scilit:
- Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Tpeak-Tend and Tpeak-Tend Dispersion as Risk Factors for Ventricular Tachycardia/Ventricular Fibrillation in Patients With the Brugada SyndromeJournal of the American College of Cardiology, 2006
- Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failureEuropean Heart Journal, 2006
- Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3Cardiovascular Research, 2005
- Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathyAmerican Heart Journal, 2003
- The M Cell:Journal of Cardiovascular Electrophysiology, 1999
- Protective effects of trimetazidine on hypoxic cardiac myocytes from the ratFundamental & Clinical Pharmacology, 1997
- The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarctionInternational Journal of Cardiology, 1996
- Assessment of QT dispersion in symptomatic patients with congenital long QT syndromesThe American Journal of Cardiology, 1992
- QT interval prolongation as predictor of sudden death in patients with myocardial infarction.Circulation, 1978